Abstract
Introduction
It is widely accepted that several factors contribute to the development of sporadic colorectal cancer (CRC) [1] ; a leading cause of cancer death worldwide [2] . There is substantial evidence that genetic and epigenetic alterations [1] , inflammatory bowel diseases [3] , and environmental factors e.g. diet [4] , contribute to the aetiology of CRC.
Worldwide it is estimated that ~30-50% of all cancer cases [4] and 54% of UK CRC cases could have been prevented through lifestyle changes [5] , emphasising the importance of cancer prevention. The impact of certain diets on the progression of CRC are beginning to be understood. For example, high-fat diets (HFD), a major contributor to obesity, have been shown to increase the risk of developing CRC by impacting on the number and tumourigenic potential of intestinal stem cells (ISCs) [6] , the cell-of-origin of CRC [7] . In contrast, several studies have documented the beneficial effects of high fibre diets against CRC [8] . Dietary fibre is fermented by colonic microbes to produce short chain fatty acids (SCFAs) such as butyrate, which is a vital source of energy for colonocytes [9, 10] . Moreover, several studies have documented the beneficial effects of the berry fruit, including black raspberries (BRB), against CRC in humans and in animal models. Specifically, diets containing BRBs have been shown to reduce ulcerative colitis (UC) in rodent models (inflammatory disease) [11] and reduce CRC tumour and polyp burdens in both mice and humans [12] [13] [14] [15] . While these studies have advanced our understanding of the impact of BRBs on CRC and have made it into clinical trials, the exact mechanisms of action remain unclear. However, it is likely that the gut microbiome plays a role, as diet is known to influence the diversity of the gut bacteria in both animals and humans [16] . This interaction between dietary intake and the microbiota has been well studied [17, 18] and it has been demonstrated in mice that the constant exposure of the large intestine to ~10 3 different commensal bacterial species, a total of ~10 14 cells, effects immune and inflammatory responses and cancer predisposition [9, [19] [20] [21] . The microbiome has an essential role in regulating normal gut homeostasis and there is a plethora of evidence indicating that specific microbial profiles may underpin many inflammatory diseases such as UC and Crohn's disease [22] , metabolic diseases such as diabetes [23] and is linked to obesity [24] , all of which have a predisposition to CRC. For example, it has been shown that obese individuals have reduced numbers of Bacteroidetes and a decreased microbial diversity and genetic abundance, while the levels of Firmicutes are elevated in these obese individuals [25, 26] . In contrast, healthy lean individuals have a greater microbial biodiversity and an increased proportion of Bacteroidetes to Firmicutes [25, 26] . Interest in the gut microbiome and their associated metabonomes in human disease including cancer [8, 27] , has placed emphasis on the need to further understand the complex underlying mechanisms involved in physiological but also pathophysiological interactions between diet-hostmicrobiome. While many studies have shown that consumption of certain dietary fibres and phytonutrients impacts the microbial diversity and function of the gut microbiota, there is limited understanding on the impact of the CRC chemopreventative fruit, BRBs, on the gastrointestinal microbiome. Here, using a longitudinal study design we examined the impact of a black raspberry-based gut microbiome modulation in a CRC setting using the Lgr5CreER T2 Apc fl/fl mouse model of CRC, which drives tumourigenesis from the intestinal stem cell. In this study, we aimed to further our knowledge of the impact of BRB consumption on the gut microbiota in a wild type and intestine at the earliest stages of malignancy to determine whether the microbiome is likely to play a role in the chemo-preventative properties of BRBs. stored at −80°C. After two weeks on their respective diets, a second faecal sample (F2) was collected prior to inducing Apc loss in the intestinal stem cells (ISC).
Lgr5CreER T2 Apc fl/fl mice were induced by intraperitoneal (IP) injection with 80 mg/kg Tamoxifen dissolved in corn oil (Sigma, UK) once daily for 4 consecutive days. This results in homozygous loss of the Apc allele in the ISC which leads to adenoma formation as previously described [7] . Twenty days post induction (d.p.i), a final faecal sample (F3) was collected prior to sacrifice. Mice were weighed three times a week from the start of the study and remained on their respective diets throughout. A schematic representation of the animal bioassay and comparisons analysed are shown in Figure 1 and Table 1 respectively.
DNA extraction
All faecal pellets were stored at −80°C immediately until required. Total bacterial DNA was extracted from the faecal samples using the FastDNA® SPIN Kit for Soil and the FastPrep® Instrument (MP Biomedicals, Santa Ana, CA), as per manufacturer details.
DNA concentrations were quantified using the Nanodrop2000 (Thermo Scientific, UK).
Sequencing and analysis of data
Total DNA extracted from faecal pellets was used for metataxonomic analysis of the V1 to V3 regions of the 16S rRNA gene. Sequence data was provided by Research and Testing Laboratory (Lubbock, TX, USA) as described previously [31] . The data was analysed using the Mothur program v 1.37.0 and the MiSeq pipeline [32] .
Statistics
Differences in the OTU data at all taxonomic levels (phylum to genus) was tested for the different interventions using STAMP [33] using White's non-parametric test and multiple test correction using the Benjamini-Hochberg FDR test, error bars are 95% confidence intervals using the DP:bootstrap method (DP = difference between mean proportions). Analysis of difference between clusters was tested using the PERMANOVA test (Adonis command in Vegan package) in R. A Shapiro-Wilk normality test was used to determine whether mouse body weights at specific time points (-14, 0 and 20 d.p.i) were normally distributed. To test for significance in % body weight change, an unpaired t-test was used, error bars represent standard error of mean. Statistical significance was defined as P ≤ 0.05. (Fig 2, orange represents mice that will be fed AIN-76A control diet and blue represents mice that will be fed BRB diet). As individual microbiomes were comparable, mice were exposed to control or BRB diets ad libitum for two weeks. Analysis of faecal samples at the F2 sampling point (Fig 1) from uninduced Apc fl/fl mice 14 days after BRB dietary modification, demonstrated a clear shift in the composition of the microbiome in a 'wild type' setting ( Fig 3A) . No individual taxonomic group, from phylum to genus level, were found to be altered when an FDR was applied, however pre-FDR analysis shows trends to support the hypothesis that BRB diet is associated with leanness after BRB fed mice appeared to have reduced Firmicutes and increased levels of Bacteriodetes compared to control (Fig 3B) . To ensure there were no adverse effects of BRB intervention on murine body weight and to monitor symptoms of intestinal tumourigenesis, all mice were weighed throughout the study (Fig 4A) . There was no significant difference in mouse % body weight at day 0, 14 and 20 d.p.i between control or BRB fed mice (Fig 4B) , however, on average BRB-fed mice appear to have slightly lower body weights then control fed mice throughout the study (Fig 4A) . 
Loss of

Further analysis at taxonomic class levels reflects increases in Bacteroides and
Clostirdium_XVIII species are the main contributors to the indicated community changes observed (Fig 5B) . However, due to the small number of samples (N=4) the changes failed to reach statistical significance when an FDR was applied. (Fig 6) . These changes in bacterial composition appear to be less than the change that occurs from ISC Apc loss in the control diet setting (Fig 5) , which indicates that BRBs can attenuate the cancer-induced microbiome alterations. Finally, we wanted to evaluate whether there were any alterations to the gut cancer microbiome as a result of BRB exposure. Surprisingly, PCA analysis on F3 samples from mice showed there were no differences in the gut microbiome composition in tumour bearing Lgr5CreER T2 Apc fl/fl mice fed control or BRB diets at 20 days post Apc loss (Fig 7) .
Two week BRB feeding prior to
Discussion
Chemoprevention refers to the use of naturally occurring or synthetic agents to reverse, suppress or delay the development of carcinogenesis [35, 36] . One of the growing concerns in the cancer field is the increase in cancer incidence globally, where there is now substantial evidence that shows the Western lifestyle is strongly attributable to several cancer types, in particular colon and liver cancer [4] . In the UK alone, it is estimated that over half of CRCs could have been prevented through lifestyle changes [5] . In recent years several studies have highlighted the benefits of natural food sources (most of which are rich fibre sources) and plant-based chemicals on human health and thus, these may be able to be modified for preventative strategies. For example, in a randomized, controlled feeding study in healthy humans, show that the gut microbiome is influenced by onset of tumourigenesis, and this modification to the gut microbiota may be minimised in the context of BRB feeding.
It has previously been documented that the murine gut microbiota can differ depending on their location (i.e. which institution they are in), inter and intra-species heterogeneity, cage effects, diet, age and stress [45, 46] . Thus, to minimise the variation in the microbiota composition of the mice at the start of the experiment, we used age-matched litter mates from one mouse colony, which were in the same room on the same rack within the animal facility. In order to accurately track the changes in the microbiome we sampled faeces from the same mice at 3 time points throughout the study, to 1) determine the impact of 2-week feeding on BRB diet on the 'normal' gut microbiome, 2) to determine the impact of Apc loss in the ISC population, which represents the initiation stage of CRC and 3) to evaluate the effect of BRBs on the gut microbiome in mice after the onset of tumourigenesis when cancerous lesions are present in the small intestine. Our results indicate that before the commencement of the control AIN-76A diet or control diet supplemented with 10% freeze-dried BRBs, the composition of the gut microbiota was similar among all 8 healthy wild type mice (uninduced Lgr5CreER T2 Apc fl/fl ) (Fig 2) . This highlights that any changes in the microbiota communities from subsequent faecal samples is from the BRB dietary modification and/ or the onset of tumourigenesis. Previous studies have demonstrated that feeding of freeze-dried BRBs and their anthocyanin-derivatives alter the microbial community of healthy wild type mice and rats [43, 44] . In support of this data, we also report herein, that 2-week feeding of BRB diet alters the composition of the murine gut microbiome compared to control diet (Fig 3A) . However, due to the small number of 4 mice per cohort, we were not able to detect any significant microbial alterations at the Phyla or Genus level, unlike the previous studies which indicated BRBs reduce the abundance of Firmicutes and increased Bacteroidetes compared to the control diet [44] , which has been observed in leaner individuals and mice [25, 47] . However, we report a similar trend of Bacteroidetes to Firmicutes ratio pre-FDR analysis (Fig 3B) .
Although not significantly altered after 2 weeks on the BRB diet, healthy mice with BRB intervention also appear to have a lower body weight on average than control fed mice, even after the onset of tumourigenesis (Fig 4A) , which may be associated to the whole community shift in the microbiome and the preferential Bacteroidetes/ Firmicutes ratio.
It is now well established that the gut microbiome is substantially altered in cancer patients, although it is unknown whether microbial changes have causative features or are a consequence of cancer onset. Several studies have documented that CRC patients tend to have more Fusobacteria, Proteobacteria, Clostridium, Dialister, Peptostreptococcus, unclassified Clostridiales and Oscillospira than control patients [48, 49] . However, some studies have reported contradictory findings on Bacteroides levels in CRC patients. While Bacteroides are usually found to be reduced in abundance in CRC patients compared to control patients [50] , another group reported that Bacteroides were increased in CRC patients [51] . It is likely that the composition of microbial communities is influenced by several factors including tumour burden and the stage of the disease and thus, results from all microbiome studies should be carefully interpreted. In our study, we report that 20 days after onset of colorectal tumourigenesis through the loss of the tumour suppressor gene Apc from the ISC compartment, resulted in a shift in the microbial community (Fig 5A) . Contrary to studies which associate increased Bacteroides with healthy weights [25, 26, 50] and thus reduced risk of obesity and CRC, we report similar trends to Sobhani et al (2011) of increased Bacteroides in tumour bearing mice (Fig 5B) . However, when an FDR was applied, these changes were not found to be significant, highlighting the need for larger cohort sizes in the future.
We next looked to evaluate whether addition of BRBs to the diet prior to tumour onset, offsets the changes to the microbial community seen in the malignant setting. We report that the microbial composition at 20 d.p.i. in BRB-fed tumour bearing mice does shift from the composition observed in the same mice prior to tumour onset (Fig 6) , however, this change in microbial community appears to be less than the shift seen in the control diet tumour setting (Fig 5A) . This suggests that BRB intervention may limit the cancer-induced microbial changes and thus, may exert a protective effect against CRC progression, however, this needs to be investigated further. When analysing the effects of BRBs on the microbiome on tumour-bearing mice at 20 d.p.i compared to control fed tumour mice we report there were no alterations to the microbial community (Fig 7) . This was somewhat surprising, given that the shift in the microbiome in BRBfed mice following Apc loss appeared to be less drastic than the shift in control fed mice following Apc loss. However, as previously eluded to, the composition of microbial communities can be influenced by tumour burden and the stage of the disease. As it has been previously reported in both animal models and human patients that BRBs protect against CRC and FAP disease by reducing tumour/polyp burden [12, 14] , it is possible that the lack of change in microbial communities may reflect differences in tumour burden in our mice. Therefore, future studies should evaluate tumour burden in these cohorts. It is also important to note, that while animal models have been invaluable in deciphering the mechanisms that cause cancer and have advanced our understanding of the microbiome, they do not fully recapitulate the human body, such that the site of tumourigenesis is different between human and mouse [52] , the baseline microbiomes would be different as a result of mice having a vegetarian diet unlike many humans [53] , and the number of tumours that form in Lgr5CreER T2 Apc fl/fl mice is not representative of the in vivo human setting, such that the induction regime used in this study results in a large tumour burden throughout the entire small intestine and colon [7] . Thus, in order to accurately decipher microbial changes and possible chemo-preventative mechanisms in the context of BRB feeding in the healthy and malignant gut, future studies using human faecal samples are essential.
As demonstrated above, the mouse gut microbiome was substantially changed by BRBs in both the healthy intestine and following tumour onset, which may have protective effects against CRC initiation and progression. However, understanding the specific interactions between the host-gut microbiome and in the context of dietary modification would enable us to develop better therapeutic strategies, thus it is important that future studies investigate potential mechanisms in both animal models but more importantly in humans. Specifically, through qRT-PCR it would be useful to characterise the effects of BRBs on specific microbes at the Genus level, and on the respective gut metabolomes in control and BRB fed mice in the healthy and malignant intestine. In particular analysing the levels of SCFAs, for example butyrate -a microbial bi-product which is the main source of colonocyte energy, that has been shown to be a potent histone deacetylase inhibitor (epigenetic regulator), antiinflammatory and have protective effects against CRC [54] , would shed light on the impact of the microbiome and the metabolome in CRC prevention. Identifying the specific microbiota altered in the context of BRB intervention may enable us to correlate any metabolic changes to particular butyrate-producing phyla, allowing us to underpin the more intricate mechanisms involved in dietary cancer chemoprevention.
In addition, given the known disturbances in epithelial barrier integrity and mucosal layers of the malignant gut [55] it would be interesting to evaluate if BRBs protect against CRC and dysbiosis by protectively regulating the epithelial barrier. Several studies have reported in CRC cell lines that butyrate stimulates mucus production and maintains epithelial integrity [56, 57] , thus it may be possible that increases in butyrateproducing microbiota may protect the intestinal epithelial from insult. Commonly associated with defects in the intestinal epithelial barrier, and a common driver of CRC is the onset of inflammation due to the presence of bacteria in the colonic tissue [58] . Previously, BRBs have been shown to reduce inflammation in murine models of ulcerative colitis [11] and CRC [12] , in rat models of oesophageal cancer [59] , and enhance natural killer cell immunology in CRC patients [60] . Specifically, in mouse models of oesophageal cancer, BRBs were found to increase the expression of the anti-inflammatory cytokine IL-10 [59] , which is associated with regulatory T cells that dampen inflammation and maintain immune homeostasis [61] , and thus, has roles in reducing cancer risk. Moreover, it has been shown that the infiltration of bacteria to the colonic epithelium of adenoma-bearing mice induces the expression the proinflammatory cytokine Th17 [58] . IL-10 is required to suppress Th17 cell-mediated inflammation [62] . It may be possible that BRB intervention modifies the microbiome to induce the expression of IL-10 to reduce Th17-mediated inflammation. However 
Conclusion
In summary, the current study demonstrated that BRB intervention was able to alter the composition of the gut microbiome in healthy and intestinal tumour-bearing mice.
These alterations in the microbial communities' present in the bowel in the context of BRB chemoprevention, may elicit protective roles against colorectal carcinogenesis, and the microbiome itself may serve a predictive biomarker to monitor at risk patients of CRC development. Tables   Table 1   Table 1 : Summary of the comparisons analysed in this longitudinal study. when an FDR is applied no one genus was shown to alter due to the feeding intervention, but the whole community shifted its composition in response to the BRB diet. N = 4 mice per cohort, error bars represent 95% confidence intervals using the DP:bootstrap method (DP = difference between mean proportions). 
